Delivery Order SPE2DR25D3103-SPE2DR26F9N87
- Not listed
- The Defense Logistics Agency awarded a $1,169.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Barhemsys 5 mg/2 ml vial (2 ml units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.95 to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on October 30, 2025, with completion expected by October 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, serves the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials totaling $1,870.98, with an ultimate completion date of October 28, 2025. This firm fixed-price, competitively awarded delivery order was issued on October 27, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a $7,385.19 delivery order by the Defense Logistics Agency (DLA) on December 9, 2025, for the supply of Barhemsys 10 mg/4 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025, and performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,094.17 delivery order to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed price, competitively awarded contract represents a single pharmaceutical supply transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and is performing under its existing...
- The Defense Logistics Agency (DLA) awarded a $21,443.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Barhemsys 10 mg/4 mL vials. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $8,906.70 to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 ml vials on December 8, 2025, with completion expected by December 9, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 ml vials with a firm fixed price ceiling value of $1,160.32. The order was competitively awarded without set-aside provisions and is scheduled for completion by December 11, 2025. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.79 to AmerisourceBergen Drug Corp for Barhemsys 10 mg/4 mL vials on December 11, 2025. The contract represents a firm fixed price delivery order with an ultimate completion date of December 12, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This award is a child...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9N87Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,256.63 to AmerisourceBergen Drug Corp for the supply of Barhemsys 10 mg/4 ml vials on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds the SPE2DX global pharmaceutical support vehicle that enables supply of a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal procurement portfolio demonstrates extensive experience fulfilling competitive pharmaceutical delivery orders through the DLA Medical Supply Chain, serving defense and civilian healthcare systems including the Defense Health Agency and U.S. Coast Guard. This delivery order for Barhemsys, a pharmaceutical product used in critical care settings, exemplifies AmerisourceBergen's ongoing role as a primary vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 12/10/25 |